Details for New Drug Application (NDA): 021203
✉ Email this page to a colleague
The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
Summary for 021203
Tradename: | TRICOR |
Applicant: | Abbvie |
Ingredient: | fenofibrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021203
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 54MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 4, 2001 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 4, 2001 | TE: | RLD: | Yes |
Expired US Patents for NDA 021203
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-001 | Sep 4, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-001 | Sep 4, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription